| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 9,812 | 9,929 | 9,283 | 9,833 | | Cost of Revenue | 3,817 | 3,943 | 4,035 | 3,372 | | | Gross Profit |
-
| 5,985 | 5,248 | 6,461 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,392 | 4,035 | 3,745 | 3,278 | | Non Recurring | (53) | (98) | 151 | (121) | | Others | 670 | 3,300 | 980 | 7,815 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (1,252) | 372 | (4,511) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,986 | (1,252) | 372 | (4,511) | | Interest Expense | 1,269 | 1,261 | 1,273 | 1,392 | | Income Before Tax | 717 | (2,513) | (900) | (5,903) | | Income Tax Expense | 142 | (881) | (308) | (2,123) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 574 | (1,632) | (592) | (3,780) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 574 | (1,632) | (592) | (3,780) | | Preferred Stock And Other Adjustments | (281) | (281) | (188) |
-
| | | Net Income Applicable To Common Shares | $293 | ($1,913) | ($780) | ($3,780) |
|
0.51% Nasdaq 
Income Statement
